http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI#head http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI http://www.nanopub.org/nschema#hasAssertion http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI#assertion http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI http://www.nanopub.org/nschema#hasProvenance http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI#provenance http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI http://www.nanopub.org/nschema#hasPublicationInfo http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI#assertion http://rdf.disgenet.org/resource/gda/DGNb574db4f46ce00eebe4cda3e50a68b1d http://semanticscience.org/resource/SIO_000628 http://identifiers.org/ncbigene/1080 http://rdf.disgenet.org/resource/gda/DGNb574db4f46ce00eebe4cda3e50a68b1d http://semanticscience.org/resource/SIO_000628 http://linkedlifedata.com/resource/umls/id/C0010674 http://rdf.disgenet.org/resource/gda/DGNb574db4f46ce00eebe4cda3e50a68b1d http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://semanticscience.org/resource/SIO_001122 http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI#provenance http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI#assertion http://purl.org/dc/terms/description [The potentiator Kalydeco� (also known as Ivacaftor or VX-770), developed by Vertex Pharmaceuticals, has been recently approved by the US FDA and the European Medicines Agency (EMA) for the treatment of CF patients carrying at least one CFTR allele with the p.Gly551Asp mutation (2-5 % of all patients).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine. http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI#assertion http://purl.org/ontology/wi/core#evidence http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI#assertion http://semanticscience.org/resource/SIO_000772 http://identifiers.org/pubmed/23757197 http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://rdf.disgenet.org/v5.0.0/void/BEFREE http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI#assertion http://www.w3.org/ns/prov#wasGeneratedBy http://purl.obolibrary.org/obo/ECO_0000203 http://rdf.disgenet.org/v5.0.0/void/BEFREE http://purl.org/pav/importedOn 2017-02-19 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://purl.obolibrary.org/obo/ECO_0000212 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#comment Gene-disease associations inferred from text-mining the literature. http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#label DisGeNET evidence - LITERATURE http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI http://purl.org/dc/terms/created 2017-10-17T13:11:32+02:00 http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI http://purl.org/dc/terms/rights http://opendatacommons.org/licenses/odbl/1.0/ http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI http://purl.org/dc/terms/rightsHolder http://rdf.disgenet.org/v5.0.0/void/IBIGroup http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI http://purl.org/dc/terms/subject http://semanticscience.org/resource/SIO_000983 http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI http://purl.org/net/provenance/ns#usedData http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI http://purl.org/pav/authoredBy http://orcid.org/0000-0001-5999-6269 http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI http://purl.org/pav/authoredBy http://orcid.org/0000-0002-7534-7661 http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI http://purl.org/pav/authoredBy http://orcid.org/0000-0002-9383-528X http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI http://purl.org/pav/authoredBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI http://purl.org/pav/authoredBy http://orcid.org/0000-0003-1244-7654 http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI http://purl.org/pav/createdBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI http://purl.org/pav/version v5.0.0.0 http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://purl.org/pav/version v5.0.0